The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards
Authors
Keywords
-
Journal
PHARMACEUTICAL STATISTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-01
DOI
10.1002/pst.1977
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The win ratio: On interpretation and handling of ties
- (2019) Gaohong Dong et al. Statistics in Biopharmaceutical Research
- Statistical Appraisal of 6 Recent Clinical Trials in Cardiology
- (2019) Stuart J. Pocock et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- On the alternative hypotheses for the win ratio
- (2018) Lu Mao BIOMETRICS
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graphing the Win Ratio and its components over time
- (2018) Dianne M. Finkelstein et al. STATISTICS IN MEDICINE
- The stratified win ratio
- (2017) Gaohong Dong et al. Journal of Biopharmaceutical Statistics
- Some statistical considerations in the clinical development of cancer immunotherapies
- (2017) Bo Huang PHARMACEUTICAL STATISTICS
- A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance
- (2017) Geraldine Rauch et al. STATISTICS IN MEDICINE
- Weighted win loss approach for analyzing prioritized outcomes
- (2017) Xiaodong Luo et al. STATISTICS IN MEDICINE
- On the win-ratio statistic in clinical trials with multiple types of event
- (2016) D. Oakes BIOMETRIKA
- A win ratio approach to comparing continuous non-normal outcomes in clinical trials
- (2016) Duolao Wang et al. PHARMACEUTICAL STATISTICS
- A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components
- (2016) Gaohong Dong et al. PHARMACEUTICAL STATISTICS
- An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring
- (2016) Julien Péron et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
- (2016) Julien Péron et al. JAMA Oncology
- Large sample inference for a win ratio analysis of a composite outcome based on prioritized components: Table 1.
- (2015) Ionut Bebu et al. BIOSTATISTICS
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- An alternative approach to confidence interval estimation for the win ratio statistic
- (2014) Xiaodong Luo et al. BIOMETRICS
- Opportunities and challenges of combined effect measures based on prioritized outcomes
- (2013) Geraldine Rauch et al. STATISTICS IN MEDICINE
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
- (2011) S. J. Pocock et al. EUROPEAN HEART JOURNAL
- Generalized pairwise comparisons of prioritized outcomes in the two-sample problem
- (2010) Marc Buyse STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More